Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the <scp>MATE</scp> randomised controlled trial)

  • Archana Airody*
  • , Heidi A. Baseler
  • , Julie Seymour
  • , Victoria Allgar
  • , Rajarshi Mukherjee
  • , Louise Downey
  • , S Dhar‐Munshi
  • , Sajjad Mahmood
  • , Konstantinos Balaskas
  • , Theo Empeslidis
  • , Rachel L.W. Hanson
  • , Tracey Dorey
  • , Tom Szczerbicki
  • , Sobha Sivaprasad
  • , Richard P. Gale
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Treatment of age‐related macular degeneration with aflibercept using a treat, extend and fixed protocol; A 4‐year study of treatment outcomes, durability, safety and quality of life (An extension to the <scp>MATE</scp> randomised controlled trial)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Nursing and Health Professions